Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Transfusion Science
|
April 20, 2000
Removal of abnormal prion protein by plasma fractionation
P R Foster, C McLean, A G Welch, et al.
Thrombosis and Haemostasis
|
October 1, 1981
Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate
C V Prowse, B Griffin, D S Pepper, et al.
Vox Sanguinis
|
January 1, 1988
Studies on the stability of VIII:C during the manufacture of a factor VIII concentrate for clinical use
P R Foster, I H Dickson, T A McQuillan, et al.
Vox Sanguinis
|
April 15, 2000
Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products
P R Foster, A G Welch, C McLean, et al.
The American Journal of Cardiology
|
October 1, 1977
Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome
D P Zipes, W E Gaum, P R Foster, et al.
Vox Sanguinis
|
March 17, 2004
Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII
P R Foster, B D Griffin, C Bienek, et al.
Circulation
|
July 27, 1999
Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators
W J Groh, S A Boschee, E D Engelstein, et al.
Vox Sanguinis
|
August 31, 2002
Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin
H E Reichl, P R Foster, A G Welch, et al.
British Journal of Haematology
|
April 1, 1987
Studies on the effect of heat treatment on the thrombogenicity of factor IX concentrates in dogs
J D Littlewood, J Dawes, J K Smith, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Transfusion Science
|
April 20, 2000
Removal of abnormal prion protein by plasma fractionation
P R Foster, C McLean, A G Welch, et al.
Thrombosis and Haemostasis
|
October 1, 1981
Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate
C V Prowse, B Griffin, D S Pepper, et al.
Vox Sanguinis
|
January 1, 1988
Studies on the stability of VIII:C during the manufacture of a factor VIII concentrate for clinical use
P R Foster, I H Dickson, T A McQuillan, et al.
Vox Sanguinis
|
April 15, 2000
Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products
P R Foster, A G Welch, C McLean, et al.
The American Journal of Cardiology
|
October 1, 1977
Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome
D P Zipes, W E Gaum, P R Foster, et al.
Vox Sanguinis
|
March 17, 2004
Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII
P R Foster, B D Griffin, C Bienek, et al.
Circulation
|
July 27, 1999
Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators
W J Groh, S A Boschee, E D Engelstein, et al.
Vox Sanguinis
|
August 31, 2002
Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin
H E Reichl, P R Foster, A G Welch, et al.
British Journal of Haematology
|
April 1, 1987
Studies on the effect of heat treatment on the thrombogenicity of factor IX concentrates in dogs
J D Littlewood, J Dawes, J K Smith, et al.
Page
of 4